MediClin AG (STU:MED) FFO


STU:MED MediClin AG STU:MED
76 GF Score
Price €3.84
GF Value €2.95
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is MediClin AG FFO?

FFO (Funds from operations) only applies to REITs.

STU:MED
76GF Score
MediClin AG STU:MED
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is MediClin AG (STU:MED) Overvalued in 2026?

Based on GuruFocus' analysis, MediClin AG stock appears to be overvalued. The current stock price of €3.84 is trading 30.2% above its estimated GF Value™ of €2.95. GuruFocus considers MediClin AG to be Modestly Overvalued.

Key valuation signals for STU:MED:

  • FFO:
  • GF Value™: €2.95 vs. price of €3.84 (30.2% above fair value)
  • GF Score™: 76/100 with 5 warning signs

No single metric tells the full story. See the STU:MED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


MediClin AG Business Description

Other Exchanges 0NDG:UKMED:Germany
Address Okenstrasse 27, Offenburg, BW, DEU, 77652
MediClin AG operates hospitals and other medical care centers. The company's reportable operating segments are the Post-acute, Acute, Nursing care, and Service segments. A majority of its revenue is generated from the Post-acute segment, which offers services in the fields of follow-up rehabilitation treatment and curative treatment. Some of the post-acute hospitals also offer services in acute neurology and acute psychosomatics. The Acute segment encompasses medical offerings with a focus on neurology and neurological early rehabilitation as well as psychosomatic medicine, psychiatry, orthopaedics, and internal medicine. The Nursing care segment offers full-time and part-time nursing care as well as daycare, and the Service segment consists of the central services.
76GF Score

Get the complete analysis for STU:MED

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.84
Price
€2.95
GF Value